WB
IBB icon

WesBanco Bank’s iShares Biotechnology ETF IBB Stock Holding History

WesBanco Bank’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Sell
3,000
-8,647
-74% -$1.49M 0.01% 482
2026
Q1 		$1.97M Hold
11,647
– – 0.05% 242
2025
Q4 		$1.97M Hold
11,647
– – 0.05% 236
2025
Q3 		$1.68M Hold
11,647
– – 0.05% 275
2025
Q2 		$1.47M Hold
11,647
– – 0.04% 288
2025
Q1 		$1.49M Sell
11,647
-50
-0.4% -$6.78K 0.05% 250
2024
Q4 		$1.55M Hold
11,697
– – 0.05% 249
2024
Q3 		$1.7M Sell
11,697
-300
-3% -$43.4K 0.06% 235
2024
Q2 		$1.65M Buy
11,997
+7,321
+157% +$977K 0.06% 217
2024
Q1 		$642K Buy
4,676
+1,200
+35% +$164K 0.02% 377
2023
Q4 		$472K Sell
3,476
-4,030
-54% -$492K 0.03% 268
2023
Q3 		$918K Sell
7,506
-600
-7% -$76.3K 0.04% 287
2023
Q2 		$1.03M Sell
8,106
-90
-1% -$11.7K 0.04% 270
2023
Q1 		$1.06M Sell
8,196
-645
-7% -$84.4K 0.05% 259
2022
Q4 		$1.16M Buy
8,841
+610
+7% +$78.8K 0.05% 247
2022
Q3 		$962K Sell
8,231
-1,600
-16% -$199K 0.07% 186
2022
Q2 		$1.16M Sell
9,831
-165
-2% -$19.6K 0.05% 248
2022
Q1 		$1.3M Hold
9,996
– – 0.05% 252
2021
Q4 		$1.53M Sell
9,996
-7,569
-43% -$1.17M 0.06% 231
2021
Q3 		$2.84M Sell
17,565
-2,637
-13% -$444K 0.11% 163
2021
Q2 		$3.31M Hold
20,202
– – 0.12% 154
2021
Q1 		$3.04M Buy
+20,202
New +$3.21M 0.12% 161
2020
Q3 		$2.86M Sell
21,108
-755
-3% -$102K 0.13% 140
2020
Q2 		$2.99M Buy
21,863
+8,049
+58% +$1.03M 0.15% 138
2020
Q1 		$1.49M Hold
13,814
– – 0.09% 190
2019
Q4 		$1.67M Hold
13,814
– – 0.08% 212
2019
Q3 		$1.37M Hold
13,814
– – 0.07% 226
2019
Q2 		$1.51M Hold
13,814
– – 0.07% 220
2019
Q1 		$1.54M Buy
13,814
+46
+0.3% +$5.04K 0.08% 208
2018
Q4 		$1.33M Hold
13,768
– – 0.08% 198
2018
Q3 		$1.68M Buy
13,768
+465
+3% +$54.8K 0.08% 206
2018
Q2 		$1.46M Hold
13,303
– – 0.08% 212
2018
Q1 		$1.42M Sell
13,303
-44
-0.3% -$4.88K 0.07% 213
2017
Q4 		$1.43M Hold
13,347
– – 0.1% 160
2017
Q3 		$1.48M Buy
13,347
+45
+0.3% +$4.81K 0.08% 199
2017
Q2 		$1.38M Sell
13,302
-60
-0.4% -$5.91K 0.07% 211
2017
Q1 		$1.31M Sell
13,362
-750
-5% -$71.8K 0.07% 205
2016
Q4 		$1.25M Hold
14,112
– – 0.07% 219
2016
Q3 		$1.36M Buy
14,112
+150
+1% +$14.3K 0.08% 193
2016
Q2 		$1.2M Hold
13,962
– – 0.07% 210
2016
Q1 		$1.21M Sell
13,962
-1,275
-8% -$114K 0.07% 202
2015
Q4 		$1.72M Sell
15,237
-150
-1% -$16.3K 0.1% 177
2015
Q3 		$1.56M Sell
15,387
-369
-2% -$44.3K 0.09% 179
2015
Q2 		$1.94M Sell
15,756
-150
-0.9% -$18K 0.11% 170
2015
Q1 		$1.82M Sell
15,906
-870
-5% -$96K 0.1% 171
2014
Q4 		$1.7M Buy
16,776
+1,635
+11% +$159K 0.09% 179
2014
Q3 		$1.38M Buy
15,141
+555
+4% +$48.7K 0.08% 199
2014
Q2 		$1.25M Sell
14,586
-1,875
-11% -$148K 0.07% 207
2014
Q1 		$1.3M Buy
16,461
+4,170
+34% +$347K 0.07% 202
2013
Q4 		$930K Buy
12,291
+4,296
+54% +$305K 0.05% 243
2013
Q3 		$559K Sell
7,995
-294
-4% -$19.3K 0.03% 307
2013
Q2 		$481K Buy
+8,289
New +$479K 0.03% 326

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

WesBanco Bank's IBB Position: Q2 2026 in Review

WesBanco Bank reduced its iShares Biotechnology ETF (IBB) stake by 74% in Q2 2026, selling an estimated $1.49M and leaving 3,000 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #482.

WesBanco Bank first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.31M in Q2 2021. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • WesBanco Bank held 3,000 shares of iShares Biotechnology ETF worth $571K as of Q2 2026.
  • WesBanco Bank sold 8,647 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.49M.
  • iShares Biotechnology ETF made up 0.01% of WesBanco Bank's portfolio in Q2 2026, its #482 holding.
  • WesBanco Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • WesBanco Bank's iShares Biotechnology ETF position peaked at $3.31M in Q2 2021.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.